08:01 AM EDT, 03/18/2025 (MT Newswires) -- RedHill Biopharma ( RDHL ) said Tuesday it intends to file a UK Marketing Authorisation Application for Talicia, which is used to treat helicobacter pylori infections.

The application will reference the FDA's approval of Talicia through the MHRA's expedited International Recognition Procedure and should be approved by Q4, the company said.

The company's shares were down more than 9.6% in recent Tuesday premarket activity.